- Home
- SGHC vs ICUI Comparison
SGHC vs ICUI Comparison
Compare SGHC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHC
- ICUI
- Stock Information
- Founded
- SGHC 2020
- ICUI 1984
- Country
- SGHC Guernsey
- ICUI United States
- Employees
- SGHC N/A
- ICUI N/A
- Industry
- SGHC Services-Misc. Amusement & Recreation
- ICUI Medical/Dental Instruments
- Sector
- SGHC Consumer Discretionary
- ICUI Health Care
- Exchange
- SGHC Nasdaq
- ICUI Nasdaq
- Market Cap
- SGHC 3.6B
- ICUI 3.6B
- IPO Year
- SGHC N/A
- ICUI 1992
- Fundamental
- Price
- SGHC $6.62
- ICUI $139.11
- Analyst Decision
- SGHC Strong Buy
- ICUI Buy
- Analyst Count
- SGHC 5
- ICUI 4
- Target Price
- SGHC $10.40
- ICUI $199.67
- AVG Volume (30 Days)
- SGHC 892.3K
- ICUI 294.5K
- Earning Date
- SGHC 05-07-2025
- ICUI 05-06-2025
- Dividend Yield
- SGHC 4.38%
- ICUI N/A
- EPS Growth
- SGHC N/A
- ICUI N/A
- EPS
- SGHC 0.01
- ICUI N/A
- Revenue
- SGHC $1,736,303,814.00
- ICUI $2,382,046,000.00
- Revenue This Year
- SGHC $18.72
- ICUI $0.21
- Revenue Next Year
- SGHC $11.20
- ICUI $2.47
- P/E Ratio
- SGHC $735.06
- ICUI N/A
- Revenue Growth
- SGHC 10.78
- ICUI 5.44
- 52 Week Low
- SGHC $2.90
- ICUI $93.36
- 52 Week High
- SGHC $8.51
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- SGHC 39.71
- ICUI 40.91
- Support Level
- SGHC $6.75
- ICUI $142.83
- Resistance Level
- SGHC $7.11
- ICUI $152.06
- Average True Range (ATR)
- SGHC 0.26
- ICUI 5.75
- MACD
- SGHC 0.00
- ICUI 0.51
- Stochastic Oscillator
- SGHC 28.26
- ICUI 52.59
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.